ProAssurance shareholders approve sale to The Doctors Company
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Free trial
  • Log in

ProAssurance shareholders approve sale to The Doctors Company

The vote paves the way for the finalization of the deal in the first half of 2026.

By Adam Kovac
June 24, 2025
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
price tags m&a deal transaction sale.png

Shareholders of ProAssurance, the last publicly traded medical malpractice specialist, voted overwhelmingly in support of the company’s acquisition by The Doctors Company on June 24.

More

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Request a free trial Already a subscriber? Log in now

Topics

News Commercial lines Medmal (Medical malpractice) M&A Insurers North America The Doctors Company
Gift this article